Advertisement
Advertisement
ROIV
Roivant Sciences Ltd. Common Shares
36.47
USDSponsored
+0.11
+0.30%
Aug 25, 15:59 UTC -4
Closed
Pre-Market
36.48
+0.02
+0.04%
ROIV Earnings Reports
Positive Surprise Ratio
ROIV beat 10 of 20 last estimates.
50%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 27 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Roivant Sciences Ltd. Common Shares earnings per share and revenue
On Aug 06, 2026, ROIV reported earnings of -0.26 USD per share (EPS) for Q1 27, beating the estimate of -0.33 USD, resulting in a 22.62% surprise. Revenue reached 1.44 million, compared to an expected 2.10 million, with a -31.26% difference. The market reacted with a +1.50% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Cabaletta Bio, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.34
Surprise
+10.69%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
Elutia Inc. Class A Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
FAQ
What were Roivant Sciences Ltd. Common Shares's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Roivant Sciences Ltd. Common Shares reported EPS of -$0.26, beating estimates by 22.62%, and revenue of $1.44M, -31.26% below expectations.
How did the market react to Roivant Sciences Ltd. Common Shares's Q1 2027 earnings?
The stock price moved up 1.5%, changed from $34.60 before the earnings release to $35.12 the day after.
When is Roivant Sciences Ltd. Common Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Roivant Sciences Ltd. Common Shares's next earnings report?
Based on --
analysts, Roivant Sciences Ltd. Common Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement